(1)
Pimsa, P. Progression Free Survival with Erlotinib in First Line Treatment EGFR Mutated Non-Small Cell Lung Cancer Stage IV in Sunpasitthiprasong Hospital. J Health Sci BCNSP 2026, 10, e287170 .